Ciprofloxacin-hybrids, Peptidomimetics, Passerini reaction, Anticancer activity, Chemosensitization activity, P-glycoprotein interactions, in vitro toxicity
Cisplatin resistance, ruthenium-cyclopentadienyl, non-small cell lung
hyaluronic acid, nanoassemblies, doxorubicin, CD44 receptor
non-small cell lung cancer, immune checkpoints inhibitors, phospholipidome, letrozole, docosahexaenoic acid